Apic Bio, Inc. — Form D/A
Apic Bio, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2019-12-30. The offering totals $40.0M, of which $30.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-12-30
- Form: D/A
- Accession: 0001759575-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $40.0M
- Amount sold: $30.2M
- Remaining: $9.8M
- Investors: 13
- Date of first sale: 2018-11-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-326334
Issuer
- Name: Apic Bio, Inc.
- CIK: 0001759575
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 35 CAMBRIDGEPARK DRIVE, SUITE 350, CAMBRIDGE, MA, 02140-2325
- Phone: 857-302-3757
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jason Dinges | Director | New Canaan, CT |
| John Reilly | Director | Dallas, TX |
| John Reilly | Executive Officer | Dallas, TX |
| Stephen Hoffman | Director | Vancouver, A1 |
| Christian Mueller | Director | Cambridge, MA |
| Stephanie O'Brien, J.D. | Director | Cambridge, MA |
Other filings by this issuer (6)
More